Daniel Kreisel, MD, PhD, Alexander S

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

Lung cancer screening: No more excuses

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Lung transplantation with donation after cardiac death donors: Long-term follow-up in a single center Nilto C. De Oliveira, MD, Satoru Osaki, MD, PhD,

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan.

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Ground glass opacity of the lung: The veil that needs lifting

Right internal thoracic artery or saphenous vein grafting

Thirteen-year experience in lung transplantation for emphysema

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer Aalok P. Patel, BS, Traves D. Crabtree,

Form ever follows function

A single-center experience of 1500 lung transplant patients

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

William M. DeCampli, MD, PhD

Benefits of resection for metachronous lung cancer

Multilevel data analysis: What? Why? How?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

The lord of the rings Antonio Miceli, MD, PhD

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Treatment Outcomes in Stage I Lung Cancer

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Yinin Hu, MD, Varun Puri, MD, Traves D

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Open thoracoabdominal aortic repair for chronic type B dissection

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Jason M. Gauthier, MD, Ruben G. Nava, MD, Daniel Kreisel, MD, PhD

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation Bryan F. Meyers, MD, Roger D. Yusen,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The thoracoabdominal saga and heroes

Prognosis and “granularity”: Building on staging foundations?

Syphilitic aortitis: The bigger picture

How much does early fundoplication for lung transplant recipients with gastroesophageal reflux disease truly help? Challenges in escaping the perils of.

Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity? Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek.

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed Melanie P. Subramanian, MD, Varun Puri, MD, MSCI

The future of cardiac surgery training: A survival guide

Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection Ankit Bharat, MD, Deepti Saini, PhD, Nancy Steward,

“The more things change…”: The challenges ahead

Varun Puri, MD, Yinin Hu, MS, Tracey Guthrie, RN, Traves D

Apples remain apples NO matter what

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

The evolution of cardiothoracic critical care

Did you like Terminator 3 better than Terminator 2

Spencer J. Melby, MD, Shane J. Larue, MD, John M

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

Journal changes and initiatives

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD

Presentation transcript:

Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center Daniel Kreisel, MD, PhD, Alexander S. Krupnick, MD, Varun Puri, MD, Tracey J. Guthrie, RN, Elbert P. Trulock, MD, Bryan F. Meyers, MD, G. Alexander Patterson, MD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 1, Pages 215-222 (January 2011) DOI: 10.1016/j.jtcvs.2010.09.009 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Survival after lung transplantation (n = 1000). B, Survival after lung transplantation stratified by quintile. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 215-222DOI: (10.1016/j.jtcvs.2010.09.009) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 A, Incidence of PGD presented for individual quintiles. B, Survival after lung transplantation stratified by PGD. BOS, Bronchiolitis obliterans syndrome; PGD, primary graft dysfunction. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 215-222DOI: (10.1016/j.jtcvs.2010.09.009) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 A, Freedom rates from BOS (n = 1000). B, Freedom rates from BOS stratified by era. C, Freedom rates from BOS stratified by PGD. BOS, Bronchiolitis obliterans syndrome; PGD, primary graft dysfunction. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 215-222DOI: (10.1016/j.jtcvs.2010.09.009) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions